We make it happen.
policy matters - contract pharma networks
Resolved to Solve
We make it happen.
policy matters - contract pharma networks
Resolved to Solve
Genesis
ICPA
International Contract Pharma Association
A Company limited by shares under
section 8 of the Companies Act, 2013
CIN U85300DL2021NPL385144.
Incorporated in August 2021. New Delhi, India.
Founded by Dr. Anil Ram Chauhan.
- MBA (International Business, Baruch College, CUNY, USA) : Ph.D. (Genetics, PAU, India)
- Well experienced professional with over 2 decades in leading biotech & Agri firms
- Director & Senior Advisor of a pan-India association for a decade.
- Widely connected with national and international stakeholders in the field of entrepreneurship, innovation and policy makers in biotech and pharmaceuticals.
Let's collaborate
It's time to get together and make a difference
the opportunity - from a choice to a strategic need
Outsourcing in the pharma/biotech industry is gaining traction and going forward the pace is bound to accelerate. At this juncture companies are ready to collaborate to not only meet urgent production and supply requirements but also to do so in a cost effective manner.
our aim
We are an Association serving contract service providers in the pharma/biotech/medical devices sectors. Our goal is to enable our members deliver services, products and solutions seamlessly across the globe. This will be achieved by articulating our members’ perspective for navigating local and international systems to help them meet their societal and business responsibilities.
Purpose, Vision & Mission
Purpose
“ Resolved to Solve” is the main purpose of ICPA that aims to synergize international expertise of contract organizations to proactively address issues regarding access of medicines, therapies and medical devices, worldwide.
Vision
Equitable access to high quality health care for all across the globe
Mission
To use resources, services, products, solutions, tools, skills, technologies and practices to support the discovery,
development, manufacture and distribution of medicines,
therapies and medical devices across the world in a cost efficient and environmentally responsible manner.
Objectives
To facilitate collaboration among service and solution providers involved in the drug discovery, development, manufacture and supply chain to enable them to be more responsive and resilient in meeting national and international demand for medicines, therapies and medical devices.
To work closely with the pharmaceutical, biotechnology, medical devices and other stakeholders to help in advance-planning by using emerging technologies to produce novel medicines, therapies and medical devices to meet current and future demand.
To work with governments, international agencies, NGOs and others on health, trade and other issues for improving ease of delivering contract services and solutions.
ICPA structure
Advisory Board
Non Executive Chairperson
Regional Co Chairs
Committee chairs
Founder Director (Secretary Advisory Board)
Office bearers
CEO, Hon. Secretary, Hon. Treasurer, Managers
ICPA Regions
Asia Pacific
EU (Schengen, Non Schengen) & UK
North America
LatAM
MEA
As ICPA activities expand, the number of co-chairs can be increased.
ICPA Committees
- Drug Discovery Legal & Arbitration
- Regulatory CSR
- Preclinical Pharmacovigilance
- Clinical Training & Education
- Manufacturing Events & Media
- Supply Chain Others
Members
Members
For-profit organizations involved in providing contract services, solutions and products to the pharmaceuticals, biotechnology and medical devices sectors
Please access membership form in the documents section
Criteria
The member organization
- Is Solvent and in good standing.
- Approved by National and or International regulatory agencies.
- Involved in providing contract services, products and solutions for pharmaceuticals, biotechnology, medical devices sectors.
- Provides or plans to provide services to international clients.
- Has fully paid the annual membership or other dues.
- Agrees to the objectives mentioned in the MOA of ICPA
- Is in agreement with the responsibilities and duties as mentioned in the sections below.
Responsibilities
- To help achieve the objectives set out in the MOA of ICPA.
- To engage and facilitate dialogue and discussion in a positive and collaborative manner.
- To champion ICPA’s initiatives to improve the ease of conducting business.
- To support ICPA in engaging with government authorities, public and private organizations, agencies, various sectors and public at large in India and abroad.
- To follow professional and ethical practices in business dealings.
- To consider and promote arbitration through ICPA to resolve any business issues with any other ICPA member or non-member.
- To promote ICPA as an important International platform in various areas of its interest..
- To help ICPA project a positive perception about the contract services industry.
- To avoid any act that affects the image of ICPA or the contract services industry
Duties
- To pay the association membership or other dues in a timely manner.
- To actively discharge the responsibilities as a ICPA member.
- To follow a transparent, legal, honest, ethical and unbiased process in professional, financial and inter-personal matters
- To be inclusive, collaborative and empathetic during the conduct of any ICPA assigned task.
- To bring to notice of the ICPA executive management any matter that needs to be addressed.
- To not raise or indulge in any political or other matter that creates rivalry, factions, ill-will or disruption of ICPA functioning or image.
- To not misuse or misrepresent the forum. logos, goodwill, provided by ICPA
Supporting Organizations & Government stakeholders
Supporting Organizations
- Organizations with objectives similar to those of ICPA.
- The Organizations will be invited by the Founder-Director or on the advice of a majority of the paying members.
- The Organizations will not be required to pay membership fees since they are not paying members.
- Will not be part of the ICPA internal committees but provide their views and suggestions on important issues.
- Invitee organizations are expected to support ICPA objectives as outlined in the MOA of ICPA and will be recognized as Supporting Organizations. They may wish to provide their logos and web links on the ICPA website. The supporting Organizations would be expected to display ICPA logo and provide a web link on their website.
- ICPA reserves the right not to accept or withdraw the supporting Organization status without assigning any reason.
- Becoming a Supporting Organization does not constitute setting up a partnership with ICPA.
Please access supporting organization form in the documents section
Government stakeholders
- A public private partnership mode of engagement will be encouraged by ICPA in its interaction with government stakeholders
- Government ministries, departments, agencies involved in the regulation, development, trade, investment etc. that directly impact the pharmaceuticals, biotechnology and medical devices industries can partner with ICPA in any of the activities.
- A suitable MOU will be framed between the Government Organization and ICPA that will govern the engagement.
Detailed objectives of ICPA as per its MOA
Please check Annexure 1 downloads section
The date is approaching fast and we’re making preparations. Don’t miss out! Please mail director@incophas.org to obtain a form link to obtain a CODE before April 19. Thereafter, register anytime before August 13. No commitment or penalty if you do not use the code
00
DaysDays
00
HrsHours
00
MinsMinutes
00
SecsSeconds
My Blog
Discussion with Director Genopole @ BIO San Diego June 1
Genopole ready to host international companies
International Contract Pharma Association
Copyright © 2024 International Contract Pharma Association - All Rights Reserved.
Powered by GoDaddy
This website uses cookies.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.